Workflow
Ustekinumab biosimilar
icon
Search documents
Dr. Reddy(RDY) - 2026 Q3 - Earnings Call Transcript
2026-01-21 15:02
Dr. Reddy’s Laboratories (NYSE:RDY) Q3 2026 Earnings call January 21, 2026 09:00 AM ET Company ParticipantsAishwarya Sitharam - Head of Investor RelationsVivek Agrawal - DirectorErez Israeli - CEOBino Pathiparampil - Head of Equity ResearchAbdul Qadir - Deputy ManagerSurya Patra - Senior VPM V Narasimham - CFOConference Call ParticipantsDamayanti Kerai - AnalystShashank Krishnakumar - Senior Research AnalystTushar Manudhane - Research AnalystForam Parekh - AnalystKunal Lakhan - Senior Research AnalystMadhav ...
Dr. Reddy(RDY) - 2026 Q3 - Earnings Call Transcript
2026-01-21 15:00
Dr. Reddy’s Laboratories (NYSE:RDY) Q3 2026 Earnings call January 21, 2026 09:00 AM ET Speaker2Good day, everyone, and welcome to the Quarter 3 FY26 earnings call of Dr. Reddy's Laboratories Limited. We appreciate your continued interest in our company. I'm Aishwarya Sitharam, Head of Investor Relations at Dr. Reddy's. Joining us today are members of the leadership team: Mr. Erez Israeli, our Chief Executive Officer, and Mr. M V Narasimham, MVN, our Chief Financial Officer. Our quarterly financial results h ...